Charlotte-Paige Rolle is an Infectious Disease physician affiliated with Orlando Clinical Research Center. OpenAlex indexes 50 publications with 1,153 citations (h-index 17); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1707 N Mills Ave
Orlando, FL 328031851
Telephone
407-647-3960Provider last certified this registry record 8 May 2024.
Clinical trials
2 registered studies on ClinicalTrials.gov matched to this name. Itemized trial rows, roles and sponsors are part of the full profile. Why? →
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year202543 payments$77,902openpaymentsdata.cms.gov ↗
- Gilead Sciences, Inc.Program year202528 payments$27,144openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
78.3%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor27%Tivicay43%Dovato30%Cabenuva15%Isentress12%Part D<11 patientsHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor12.7%Pifeltro100%Part D<11 patients+ 6 more classes in this area
Cardiovascular
9%Statin4.6%Rosuvastatin Calcium54%Atorvastatin Calcium46%Part D<11 patientsACE inhibitor2.3%Lisinopril100%Part D<11 patients+ 1 more class in this area
Nervous system
5.3%Antihistamine2.6%Hydroxyzine Hcl100%Part D<11 patientsSSRI2.6%Trazodone Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Derrick W. Crook
Nuffield Orthopaedic Centre
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”